Global Rise in Drug-Resistant Fungi
Analysis based on 9 articles · First reported Apr 15, 2026 · Last updated Apr 16, 2026
The increasing resistance of fungi to existing antifungal medicines poses a long-term threat to global health and food supplies, potentially increasing healthcare costs and impacting agricultural productivity. This could lead to increased demand for new antifungal treatments and surveillance technologies.
A global consortium of fifty researchers, including those from the University of Manchester, has issued a warning about the escalating resistance of fungi to available medicines. This resistance is observed in both environmental and clinical settings, driven by the similarity between agricultural fungicides and human antifungal treatments. The researchers propose a five-step plan to enhance awareness, surveillance, infection control, responsible drug use, and investment in new treatments, aiming to influence the World Health Organization's updated Global Action Plan on antimicrobial resistance. Dangerous drug-resistant fungi like Trichophyton indotineae, Candida auris, and Aspergillus fumigatus are spreading, posing significant risks, especially to immunocompromised patients. Experts, including Professor Mike Bromley, Professor Paul Verweij, and Professor Michaela Lackner, emphasize the urgent need for coordinated action across science, farming, healthcare, and policy to mitigate these risks.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard